Enzo Biochem (ENZ)
(Delayed Data from NYSE)
$1.14 USD
+0.03 (2.70%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $1.12 -0.02 (-1.75%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ENZ 1.14 +0.03(2.70%)
Will ENZ be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ENZ based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ENZ
Zacks Initiates Coverage of Enzo Biochem With Neutral Recommendation
Enzo Biochem (ENZ) Q3 Earnings Improve Y/Y, Gross Margin Up
ENZ: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ENZ
Enzo Biochem penalized $4.5M over data breach
Rare Stock Picks In July 2024 - From 29 Discerning Analysts
Enzo Biochem Board Member Resigns to Pursue New Opportunities
Enzo Biochem: Is This Time Finally Different?